Adherence to antiretroviral therapy and its correlates among HIV-infected children at an HIV clinic in New Delhi

References

• Starr SE, Fletcher CV, Spector SA, et al.. Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team. N Engl J Med 1999; 341:1874–81.
   PubMed Web of Science ®Google Scholar
• van Rossum AM, Geelen SP, Hartwig NG, et al.. Results of 2 years of treatment with protease inhibitor-containing antiretroviral therapy in Dutch children infected with human immunodeficiency virus type 1. Clin Infect Dis 2002; 34:1008–16.
   PubMed Web of Science ®Google Scholar
• Haynes RB. Compliance in Health Care (MD thesis). Baltimore, MA: Johns Hopkins University, 1979.
   Google Scholar
• Gortmaker SL, Hughes M, Cervia J, et al.. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med 2001; 345:1522–8.
   PubMed Web of Science ®Google Scholar
• Paterson DL, Swindells S, Mohr J, et al.. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133:21–30.
   PubMed Web of Science ®Google Scholar
• Fogarty L, Roter D, Larson S, Burke J, Gillespie J, Levy R. Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Educ Couns 2002; 46:93–108.
   PubMed Web of Science ®Google Scholar
• Simoni JM, Montgomery A, Martin E, New M, Demas PA, Rana S. Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management. Pediatrics 2007; 119:e1371–83.
   PubMed Web of Science ®Google Scholar
• Patients Alive and on ART, August 2010. http://www.nacoonline.org/upload/Care%20&%20Treatment/Patients%20alive%20and%20on%20ART/On%20ART%20March%202010.pdf
   Google Scholar
• Sarna A, Pujari S, Sengar AK, Garg R, Gupta I, van Dam J. Adherence to antiretroviral therapy and its determinants amongst HIV patients in India. Indian J Med Res 2008; 127:28–36.
   PubMed Web of Science ®Google Scholar
• Havens PL, Gibb DM. Increasing antiretroviral drug access for children with HIV infection. Pediatrics 2007; 119:838–45.
   PubMed Web of Science ®Google Scholar
• Vreeman RC, Wiehe SE, Pearce EC, Nyandiko WM. A systematic review of pediatric adherence to antiretroviral therapy in low- and middle-income countries. Pediatr Infect Dis J 2008; 27:686–91.
   PubMed Web of Science ®Google Scholar
• Biadgilign1 S, Deribew A, Amberbir A, de Deribe K. Adherence to highly active antiretroviral therapy and its correlates among HIV infected pediatric patients in Ethiopia. BMC Pediatr 2008; 8:53.
   PubMed Web of Science ®Google Scholar
• Polisset J, Ametonou F, Arrive E, Aho A, Perez F. Correlates of adherence to antiretroviral therapy in HIV-infected children in Lomé, Togo, West Africa. AIDS Behav 2009; 13:23–32.
   PubMed Web of Science ®Google Scholar
• Wrubel J, Moskowitz JT, Richards TA, Prakke H, Acree M, Folkman S. Pediatric adherence: perspectives of mothers of children with HIV. Soc Sci Med 2005; 61:2423–33.
   PubMed Web of Science ®Google Scholar
• Nyandiko WM, Ayaya S, Nabakwe E, et al.. Outcome of HIV-infected orphaned and non-orphaned children on antiretroviral therapy in western Kenya. J Acquir Immune Defic Syndr 2006; 43:418–25.
   PubMed Web of Science ®Google Scholar
• Vreeman RC, Wiehe SE, Ayaya SO, Musick BS, Nyandiko WM. Association of antiretroviral and clinic adherence with orphan status among HIV-infected children in western Kenya. J Acquir Immun Defic Syndr 2008; 49:163–70.
   PubMed Web of Science ®Google Scholar
• Giacomet V, Albano F, Starace F, de Franciscis A, Giaquinto C, Gattinara GC. Adherence to antiretroviral therapy and its determinants in children with human immunodeficiency virus infection: a multicentre, national study. Acta Pediatr 2003; 92:1398–1402.
   PubMed Web of Science ®Google Scholar
• Safreed-Harmon K, Siripong A, Kerr SJ, Gruskin S, Pancharoen C, Ananworanich J. Antiretroviral therapy adherence did not differ between Thai children with biological and those with nonbiological parents. Clin Infect Dis 2007; 45:669–70.
   PubMed Web of Science ®Google Scholar
• Cupsa A, Gheonea C, Bulucea D, Dinescu S. Factors with a negative influence on compliance to antiretroviral therapies. Ann NY Acad Sci 2000; 918:351–4.
   PubMed Web of Science ®Google Scholar
• Evans-Gilbert T, Pierre R, Steel-Duncan JC, et al.. Antiretroviral drug therapy in HIV-infected Jamaican children. West Indian Med J 2004; 53:322–6.
   PubMed Web of Science ®Google Scholar
• Bikaako-Kajura W, Luyirika E, Purcell DW, et al.. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav 2006; 10:S85–93.
   PubMed Web of Science ®Google Scholar
• Waugh S. Parental views on disclosure of diagnosis to their HIV-positive children. AIDS Care 2003; 15:169–76.
   PubMed Web of Science ®Google Scholar
• Blasini I, Chantry C, Cruz C, et al.. Disclosure model for pediatric patients living with HIV in Puerto Rico: design, implementation, and evaluation. J Dev Behav Pediatr 2004; 25:1–189.
   PubMed Web of Science ®Google Scholar
• Davies M, Boulle A, Fakir T, Nuttall J, Eley B. Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study. BMC Pediatr 2008; 8:34.
   PubMed Web of Science ®Google Scholar
• Williams PL, Storm D, Montepiedra G, Nichols S, Kammerer B, Sirois PA. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection. Pediatrics 2006; 118:e1745–57.
   PubMed Web of Science ®Google Scholar
• Marhefka SL, Farley JJ, Rodrigue JR, Sandrik LL, Sleasman JW, Tepper VJ. Clinical assessment of medication adherence among HIV-infected children: examination of the Treatment Interview Protocol (TIP). AIDS Care 2004; 16:323–38.
   PubMed Web of Science ®Google Scholar
• Fassinou P, Elenga N, Rouet F, et al.. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Côte d’Ivoire. AIDS 2004; 18:1905–13.
   PubMed Web of Science ®Google Scholar
• Pontali E. Facilitating adherence to highly active antiretroviral therapy in children with HIV infection: what are the issues and what can be done? Paediatr Drugs 2005; 7:137–49.
   PubMedGoogle Scholar
• Gibb DM, Goodall RL, Giacomet V, McGee L, Compagnucci A, Lyall H. Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial. Pediatr Infect Dis J 2003; 22:56–62.
   PubMed Web of Science ®Google Scholar
• Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ. The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatr Infect Dis J 2004; 23:1035–41.
   PubMed Web of Science ®Google Scholar
• Martin S, Elliott-DeSorbo DK, Wolters PL, et al.. Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents. Pediatr Infect Dis J 2007; 26:61–7.
   PubMed Web of Science ®Google Scholar